New Key Statistics Module, Z-Score and F-Score
NAS:IKNA Key Ratios
| Market Cap $ M | 73.83 |
| Enterprise Value $ M | -55.80 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.55 |
| Price/Sales | 109.29 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -1.22 |
| Beneish M-Score | -7.34 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.76 |
| EV-to-EBITDA | 0.77 |
| PEG | -- |
| Shares Outstanding M | 48.26 |
| Net Margin (%) | -9,043.85 |
| Operating Margin % | -9,755.24 |
| Pre-tax Margin (%) | -9,053.41 |
| Quick Ratio | 15.32 |
| Current Ratio | 15.32 |
| ROA % (ttm) | -33.61 |
| ROE % (ttm) | -39.34 |
| ROIC % (ttm) | -374.12 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.28 |
IKNA Number of Guru Trades
IKNA Volume of Guru Trades
Gurus Latest Trades with NAS:IKNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:IKNA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Ikena Oncology Inc Insider Transactions
No Available Data
News about NAS:IKNA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers